Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 71 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Mantzoros, Christos S [Clear All Filters]
Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study..
Metabolism. 154005.
(2019). Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics..
Metabolism. 92, 82-97.
(2019). Obesity: seize the day, fight the fat..
Metabolism. 92, 1-5.
(2019). Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns..
Metabolism. 104, 154144.
(2020). Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?.
Metabolism. 96, vi-xi.
(2019). Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis..
Heart. 107(2), 150-158.
(2021). Outliers of bone metabolic diseases..
Metabolism. 80, 1-4.
(2018). Pharmacotherapy of obesity: Available medications and drugs under investigation..
Metabolism. 92, 170-192.
(2019). Pharmacotherapy of type 2 diabetes: An update..
Metabolism. 78, 13-42.
(2018). Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis..
Metabolism. 87, 18-24.
(2018). Reproductive Endocrinology: Novel Insights into Pathophysiology and Clinical Management..
Metabolism. 86, 1-2.
(2018). Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease..
Metabolism. 147, 155676.
(2023). Sarcopenia: still in relative definition-penia and severe treatment-penia..
Metabolism. 155717.
(2023). SERUM ADIPONECTIN AND INSULIN-LIKE GROWTH FACTOR 1 IN PREDOMINANTLY FEMALE PATIENTS WITH THYROID CANCER: ASSOCIATION WITH THE HISTOLOGIC CHARACTERISTICS OF THE TUMOR..
Endocr Pract. 22(1), 68-75.
(2016). Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study..
J Clin Endocrinol Metab. 104(2), 349-358.
(2019). Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead..
Metabolism. 78, A4-A9.
(2018). Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study..
Clin Nutr. 41(6), 1281-1289.
(2022). Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease..
Metabolism. 61(6), 755-8.
(2012). Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD..
J Clin Endocrinol Metab.
(2019). An update on the validity of irisin assays and the link between irisin and hepatic metabolism..
Metabolism. 64(9), 937-42.
(2015).